July 2024
1. OGBUE O, Kewan T, Bravo-Perez C, Unlu S, et al
   Hemolytic versus malproductive anemia in large granular lymphocytic leukemia.
   Leukemia. 2024 Jul 9. doi: 10.1038/s41375-024-02323.
   

   >> Share

   
   June 2024
2. WAKAMATSU M, Muramatsu H, Sato H, Ishikawa M, et al
   Integrated proteogenomic analysis for inherited bone marrow failure syndrome.
   Leukemia. 2024;38:1256-1265.
   

   >> Share

   
   January 2024
3. DUARTE TL, Lopes M, Oliveira M, Santos AG, et al
   Iron overload induces dysplastic erythropoiesis and features of myelodysplasia in Nrf2-deficient mice.
   Leukemia. 2024;38:96-108.
   

   >> Share

   
   
4. LI C, Xu J, Luo W, Liao D, et al
   Bispecific CS1-BCMA CAR-T cells are clinically active in relapsed or refractory multiple myeloma.
   Leukemia. 2024;38:149-159.
   

   >> Share

   
   December 2023
5. LIU Y, Karlsson S
   Correction: Perspectives of current understanding and therapeutics of Diamond-Blackfan anemia.
   Leukemia. 2023 Dec 13. doi: 10.1038/s41375-023-02101.
   

   >> Share

   
   November 2023
6. LIU Y, Karlsson S
   Perspectives of current understanding and therapeutics of Diamond-Blackan anemia.
   Leukemia. 2023 Nov 16. doi: 10.1038/s41375-023-02082.
   

   >> Share

   
   
7. BAUER K, Machherndl-Spandl S, Kazianka L, Sadovnik I, et al
   CAR virus receptor mediates erythroid differentiation and migration and is downregulated in MDS.
   Leukemia. 2023;37:2250-2260.
   

   >> Share

   
   October 2023
8. FATTIZZO B, Gurnari C, Cassanello G, Bortolotti M, et al
   Deciphering treatment patterns in non-severe/moderate aplastic anemia: an international observational study.
   Leukemia. 2023 Oct 4. doi: 10.1038/s41375-023-02047.
   

   >> Share

   
   August 2023
9. TSUJI N, Hosokawa K, Urushihara R, Tanabe M, et al
   Correction: Frequent HLA-DR loss on hematopoietic stem progenitor cells in patients with cyclosporine-dependent aplastic anemia carrying HLA-DR15.
   Leukemia. 2023 Aug 25. doi: 10.1038/s41375-023-02011.
   

   >> Share

   
   
10. SEKERES MA, Montesinos P, Novak J, Wang J, et al
    Glasdegib plus intensive or non-intensive chemotherapy for untreated acute myeloid leukemia: results from the randomized, phase 3 BRIGHT AML 1019 trial.
    Leukemia. 2023 Aug 21. doi: 10.1038/s41375-023-02001.
    

    >> Share

    
    June 2023
11. MARION W, Koppe T, Chen CC, Wang D, et al
    RUNX1 mutations mitigate quiescence to promote transformation of hematopoietic progenitors in Fanconi anemia.
    Leukemia. 2023 Jun 30. doi: 10.1038/s41375-023-01945.
    

    >> Share

    
    
12. GALE RP, Hinterberger W, Young NS, Gennery AR, et al
    What causes aplastic anaemia?
    Leukemia. 2023;37:1191-1193.
    

    >> Share

    
    May 2023
13. NIKITIN E, Kislova M, Morozov D, Belyakova V, et al
    Ibrutinib in combination with rituximab is highly effective in treatment of chronic lymphocytic leukemia patients with steroid refractory and relapsed autoimmune cytopenias.
    Leukemia. 2023 May 18. doi: 10.1038/s41375-023-01891.
    

    >> Share

    
    February 2023
14. HUBER S, Haferlach T, Meggendorfer M, Hutter S, et al
    Mutations in spliceosome genes in myelodysplastic neoplasms and their association to ring sideroblasts.
    Leukemia. 2023;37:500-502.
    

    >> Share

    
    October 2022
15. PAGLIUCA S, Gurnari C, Hercus C, Hergalant S, et al
    Molecular landscape of immune pressure and escape in aplastic anemia.
    Leukemia. 2022 Oct 17. pii: 10.1038/s41375-022-01723.
    

    >> Share

    
    September 2022
16. MESA R, Harrison C, Oh ST, Gerds AT, et al
    Overall survival in the SIMPLIFY-1 and SIMPLIFY-2 phase 3 trials of momelotinib in patients with myelofibrosis.
    Leukemia. 2022;36:2261-2268.
    

    >> Share

    
    August 2022
17. KELKKA T, Tyster M, Lundgren S, Feng X, et al
    Anti-COX-2 autoantibody is a novel biomarker of immune aplastic anemia.
    Leukemia. 2022 Aug 5. pii: 10.1038/s41375-022-01654.
    

    >> Share

    
    July 2022
18. GROARKE EM, Patel BA, Shalhoub R, Gutierrez-Rodrigues F, et al
    Predictors of clonal evolution and myeloid neoplasia following immunosuppressive therapy in severe aplastic anemia.
    Leukemia. 2022 Jul 27. pii: 10.1038/s41375-022-01636.
    

    >> Share

    
    May 2022
19. HUANG Y, Chen M, Yang C, Ruan J, et al
    Sirolimus is effective for refractory/relapsed/intolerant acquired pure red cell aplasia: results of a prospective single-institutional trial.
    Leukemia. 2022;36:1351-1360.
    

    >> Share

    
    
20. KOMROKJI RS, Platzbecker U, Fenaux P, Zeidan AM, et al
    Luspatercept for myelodysplastic syndromes/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis.
    Leukemia. 2022;36:1432-1435.
    

    >> Share

    
    April 2022
21. TSUJI N, Hosokawa K, Urushihara R, Tanabe M, et al
    Frequent HLA-DR loss on hematopoietic stem progenitor cells in patients with cyclosporine-dependent aplastic anemia carrying HLA-DR15.
    Leukemia. 2022 Apr 26. pii: 10.1038/s41375-022-01549.
    

    >> Share

    
    
22. SWOBODA DM, Kanagal-Shamanna R, Brunner AM, Cluzeau T, et al
    Marrow ring sideroblasts are highly predictive for TP53 mutation in MDS with excess blasts.
    Leukemia. 2022;36:1189-1192.
    

    >> Share

    
    January 2022
23. LIN Q, Lian J, Wu J, Meng P, et al
    Erythropoietin receptor contributes to thrombopoietin receptor (Mpl)-independent thrombocytopoiesis in zebrafish.
    Leukemia. 2022 Jan 18. pii: 10.1038/s41375-021-01495.
    

    >> Share

    
    October 2021
24. ZHOU C, Kuang M, Liu Z, Jia X, et al
    Insufficiency of FZR1 disturbs HSC quiescence by inhibiting ubiquitin-dependent degradation of RUNX1 in aplastic anemia.
    Leukemia. 2021 Oct 11. pii: 10.1038/s41375-021-01445.
    

    >> Share

    
    September 2021
25. CERVANTES F, Ross DM, Radinoff A, Palandri F, et al
    Correction: Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study.
    Leukemia. 2021 Sep 2. pii: 10.1038/s41375-021-01396.
    

    >> Share

    
    August 2021
26. FEURSTEIN S, Churpek JE, Walsh T, Keel S, et al
    Germline variants drive myelodysplastic syndrome in young adults.
    Leukemia. 2021;35:2439-2444.
    

    >> Share

    
    
27. GURNARI C, Pagliuca S, Patel BJ, Awada H, et al
    Implication of PIGA genotype on erythrocytes phenotype in Paroxysmal Nocturnal Hemoglobinuria.
    Leukemia. 2021;35:2431-2434.
    

    >> Share

    
    June 2021
28. GURNARI C, Durrani J, Pagliuca S, Kishtagari A, et al
    Novel invariant features of Good syndrome.
    Leukemia. 2021;35:1792-1796.
    

    >> Share

    
    May 2021
29. CERVANTES F, Ross DM, Radinoff A, Palandri F, et al
    Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study.
    Leukemia. 2021 May 20. pii: 10.1038/s41375-021-01261.
    

    >> Share

    
    April 2021
30. YOROIDAKA T, Hosokawa K, Imi T, Mizumaki H, et al
    Hematopoietic stem progenitor cells lacking HLA differ from those lacking GPI-anchored proteins in the hierarchical stage and sensitivity to immune attack in patients with acquired aplastic anemia.
    Leukemia. 2021 Apr 6. pii: 10.1038/s41375-021-01202.
    

    >> Share

    
    
31. ZHANG L, Chen JY, Kerr C, Cobb BA, et al
    Reduced red blood cell surface level of Factor H as a mechanism underlying paroxysmal nocturnal hemoglobinuria.
    Leukemia. 2021;35:1176-1187.
    

    >> Share

    
    March 2021
32. LUNDGREN S, Keranen MAI, Kankainen M, Huuhtanen J, et al
    Somatic mutations in lymphocytes in patients with immune-mediated aplastic anemia.
    Leukemia. 2021 Mar 30. pii: 10.1038/s41375-021-01231.
    

    >> Share

    
    
33. SEYFRIED AN, McCabe A, Smith JNP, Calvi LM, et al
    CCR5 maintains macrophages in the bone marrow and drives hematopoietic failure in a mouse model of severe aplastic anemia.
    Leukemia. 2021 Mar 20. pii: 10.1038/s41375-021-01219.
    

    >> Share

    
    
34. FATTIZZO B, Ireland R, Dunlop A, Yallop D, et al
    Clinical and prognostic significance of small paroxysmal nocturnal hemoglobinuria clones in myelodysplastic syndrome and aplastic anemia.
    Leukemia. 2021 Mar 4. pii: 10.1038/s41375-021-01190.
    

    >> Share

    
    November 2020
35. SPORTOLETTI P, Sorcini D, Guzman AG, Reyes JM, et al
    Bcor deficiency perturbs erythro-megakaryopoiesis and cooperates with Dnmt3a loss in acute erythroid leukemia onset in mice.
    Leukemia. 2020 Nov 6. pii: 10.1038/s41375-020-01075.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share